Skip to content

Supermicrosurgical Lymphvenous Bypass Intervention for Treatment

Supermicrosurgical Lymphvenous Bypass Intervention for Lymphedema Treatment

Status
UNKNOWN
Phases
Unknown
Study type
Observational
Source
ClinicalTrials.gov
Registry ID
NCT05270629
Enrollment
87
Registered
2022-03-08
Start date
2021-09-06
Completion date
2022-09-05
Last updated
2022-03-08

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Lymphedema of Leg

Brief summary

Background: In addition to antegrade anastomosis, retrograde anastomosis has been thought to offer further improvements after lymphaticovenous anastomosis (LVA) by bypassing the retrograde lymphatic flow. However, this concept has yet to be validated. The aim of this study was to determine the impacts on outcomes of performing both retrograde and antegrade anastomosis, as compared to antegrade-only anastomosis for treating lower limb lymphedema.

Interventions

OTHERAntegrade and retrograde anastomoses

Patients who had received both antegrade and retrograde anastomoses.

OTHERAntegrade-only anastomoses

Patients who had received antegrade-only anastomoses.

Sponsors

Chang Gung Memorial Hospital
Lead SponsorOTHER

Study design

Observational model
CASE_CONTROL
Time perspective
RETROSPECTIVE

Eligibility

Sex/Gender
ALL
Age
18 Years to 100 Years
Healthy volunteers
No

Inclusion criteria

* Lower limb lymphedema patients.

Exclusion criteria

* Patients who have had previous LVA, liposuction, or excisional therapy such as the Charles procedure were excluded.

Design outcomes

Primary

MeasureTime frameDescription
Magnetic resonance volumetry6 months after LVAMagnetic resonance volumetry was used for outcome assessments. The primary endpoint was the volume change at 6 months after LVA.

Countries

Taiwan

Contacts

Primary ContactChing-Hua Hsieh, PhD
m93chinghua@gmail.com+886-7-7317123

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026